NHS to trial “artificial pancreas” for patients with type 1 diabetesBMJ 2021; 373 doi: https://doi.org/10.1136/bmj.n1538 (Published 15 June 2021) Cite this as: BMJ 2021;373:n1538
- Gareth Iacobucci
- The BMJ
Up to 1000 patients with type 1 diabetes will be fitted with an “artificial pancreas” in a landmark trial, NHS England has announced.
The “closed loop” technology automatically balances blood sugar levels by constantly measuring glucose levels and delivering insulin directly to the bloodstream, when needed, through a pump. It is designed to offer better glucose control, reduce the risk of hypoglycaemia, and remove the need for finger prick tests.
Announcing the trial at the NHS Confederation’s virtual conference on 15 April, NHS England’s chief executive Simon Stevens said the technology marked a new …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.